All Posts: neuroscience
-
Researchers Decode How Cancer Drug Works in Brains of Parkinson’s Disease Patients
MEDIA CONTACT:Karen Teberkm463@georgetown.edu WASHINGTON (March 12, 2019) — Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson’s disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms […]
Category: News Release
-
Georgetown Physician Leads International Experts in Developing Treatment Guidelines for Huntington’s Disease Symptoms
(February 1, 2019) — A group of international experts in Huntington’s disease, led by Georgetown University Medical Center’s Karen Anderson, MD, has developed consensus guidelines for the clinical management of behavior symptoms caused by the incurable disease. Huntington’s disease is a fatal genetic disorder that impacts a person’s physical and mental abilities that is often accompanied […]
Category: GUMC Stories
-
Researchers Find Inhibiting One Protein Destroys Toxic Clumps Seen in Parkinson’s Disease
MEDIA CONTACT (ONLY, PLEASE):Karen Teberkm463@georgetown.edu WASHINGTON (November 14, 2018) — A defining feature of Parkinson’s disease is the clumps of alpha-synuclein protein that accumulate in the brain’s motor control area, destroying dopamine-producing neurons. Natural processes can’t clear these clusters, known as Lewy bodies, and no one has demonstrated how to stop the build up as well […]
Category: News Release
-
Georgetown Study Investigates Memory Improvement Through Nicotine Dosing
A new study being conducted at Georgetown University Medical Center aims to find out if nicotine can slow or stop memory loss in people experiencing mild memory problems.
Category: News Release
-
Making Sense of Senses: Researchers Find the Brain Processes Sight and Sound in the Same Two-Step Manner
A new study published by senior investigator Maximilian Riesenhuber, PhD, a professor in Georgetown University School of Medicine’s Department of Neuroscience, and fellow Georgetown neuroscientists Xiong Jiang, PhD; Mark A. Chevillet; and Josef P. Rauschecker, PhD, is the first to provide strong evidence that learning in sight and sound follows similar principles.
Category: News Release
-
If Your Child is Bilingual, Learning Additional Languages Later Might be Easier
It is often claimed that bilinguals are better than monolinguals at learning languages. Now, the first study to examine bilingual and monolingual brains as they learn an additional language offers new evidence that supports this hypothesis, researchers say.
Category: News Release
-
Agent Clears Toxic Proteins, Reduces Inflammation and Improves Cognition in Neurodegeneration Models
LONDON (July 16, 2017) — Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance. These dual findings, presented by Georgetown University Medical Center (GUMC) researchers at […]
Category: News Release
-
Georgetown University Licenses Use of Tyrosine Kinase Inhibitors for Treatment of Neurodegenerative Diseases
Georgetown University today announces it has exclusively licensed worldwide intellectual property (IP) rights to develop and commercialize uses of tyrosine kinase (TK) inhibitors for the treatment of neurodegenerative diseases to Axovant Sciences GmbH.
Category: News Release
-
New Clinical Trial Will Test Cancer Drug as Alzheimer's Treatment
The following is a press release issued by the ADDF: NEW YORK (September 29, 2016) – The Alzheimer’s Drug Discovery Foundation (ADDF) announces a $2.1 million grant awarded to R. Scott Turner, MD,
Category: News Release
-
Resveratrol Appears to Restore Blood-Brain Barrier Integrity in Alzheimer’s Disease
TORONTO (July 27, 2016) — Resveratrol, given to Alzheimer’s patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues, say researchers at Georgetown University Medical Center. The reduction in neuronal inflammation slowed the cognitive decline of patients, […]
Category: News Release